COVID-19-induced sarcopenia and physical deconditioning may require reassessment of surgical risk for patients with cancer.

Patrick CaseyYeng AngJaved Sultan

Published in: World journal of surgical oncology (2021)

Further mechanistic research is required to explore the processes behind the deconditioning effects of SARS-CoV-2 infection and how this impacts on treatment of malignant disease.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
physical activity
high glucose
mental health
skeletal muscle
drug induced
endothelial cells